Hans Peter Hasler

HPH Consulting

Mr Hasler is an independent consultant and Executive Chairman of Eidetica Biopharmaceutical a spin-off from Idec-Biogen. Past COO Biogen Idec responsible for all Commercial Operations, Business Development, Medical Affairs and Biogen International.  Dr Hasler has a long track record in biotech and pharmaceutical companies. Currently he is Director of the Board of Acino Holding AG, Basel (formerly Schweizerhall Holding, Zürich), Vice Chairman of Santhera Pharma AG, Basel and Director of the Board of HBM BioVentures, Zug.


Back to overview